Terms: = Head and neck cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105 AND Treatment
15 results:
1. Wearing individualized 3D printed oral stent to protect normal tissues in patients with nasopharyngeal carcinoma during radiotherapy.
Yang W; Yang Z; Pan W; Li H; Zhao T; Meng Y; Ma G; Ye H; Shang J
J Appl Clin Med Phys; 2023 Dec; 24(12):e14145. PubMed ID: 37676885
[TBL] [Abstract] [Full Text] [Related]
2. neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study.
Wang G; Huang C; Yang K; Guo R; Qiu Y; Li W; Mao Y; Tang L; Ma J
Radiother Oncol; 2022 Dec; 177():205-213. PubMed ID: 36375564
[TBL] [Abstract] [Full Text] [Related]
3. A direct negative feedback loop of miR-4721/foxa1/Nanog promotes nasopharyngeal cell stem cell enrichment and metastasis.
Zhao M; Tang Z; Wang Y; Ding J; Guo Y; Gao T
J Transl Med; 2021 Sep; 19(1):387. PubMed ID: 34503528
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of prognostic factors in patients with lymph node recurrence after radical esophagectomy: importance of locoregional therapy.
Tanaka K; Yamasaki M; Makino T; Yamashita K; Saitoh T; Takahashi T; Kurokawa Y; Nakajima K; Motoori M; Kimura Y; Mano M; Mori M; Eguchi H; Doki Y
Esophagus; 2021 Apr; 18(2):195-202. PubMed ID: 32875459
[TBL] [Abstract] [Full Text] [Related]
5. foxa1-induced LINC01207 facilitates head and neck squamous cell carcinoma via up-regulation of TNRC6B.
Chen C; Jiang L; Zhang Y; Zheng W
Biomed Pharmacother; 2020 Aug; 128():110220. PubMed ID: 32450521
[TBL] [Abstract] [Full Text] [Related]
6. Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations.
Wang F; Yan Z; Lv J; Xin J; Dang Y; Sun X; An Y; Qi Y; Jiang Q; Zhu W; Li Y; Li A; Guo X
Neoplasia; 2019 Jun; 21(6):571-581. PubMed ID: 31048097
[TBL] [Abstract] [Full Text] [Related]
7. Oleanolic acid inhibits cell proliferation migration and invasion and induces SW579 thyroid cancer cell line apoptosis by targeting forkhead transcription factor A.
Duan L; Yang Z; Jiang X; Zhang J; Guo X
Anticancer Drugs; 2019 Sep; 30(8):812-820. PubMed ID: 30882397
[TBL] [Abstract] [Full Text] [Related]
8. PLOD2 regulated by transcription factor foxa1 promotes metastasis in NSCLC.
Du H; Chen Y; Hou X; Huang Y; Wei X; Yu X; Feng S; Wu Y; Zhan M; Shi X; Lin S; Lu L; Yuan S; Sun L
Cell Death Dis; 2017 Oct; 8(10):e3143. PubMed ID: 29072684
[TBL] [Abstract] [Full Text] [Related]
9. MicroRNA-132 sensitizes nasopharyngeal carcinoma cells to cisplatin through regulation of forkhead box A1 protein.
Li YL; Zhao YG; Chen B; Li XF
Pharmazie; 2016 Dec; 71(12):715-718. PubMed ID: 29442000
[TBL] [Abstract] [Full Text] [Related]
10. treatment and Survival Trends in Glottic Carcinoma in Situ and Stage I cancer From 1988 to 2012.
Khaja SF; Hoffman HT; Pagedar NA
Ann Otol Rhinol Laryngol; 2016 Apr; 125(4):311-6. PubMed ID: 26481178
[TBL] [Abstract] [Full Text] [Related]
11. Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis.
Sano M; Aoyagi K; Takahashi H; Kawamura T; Mabuchi T; Igaki H; Tachimori Y; Kato H; Ochiai A; Honda H; Nimura Y; Nagino M; Yoshida T; Sasaki H
Int J Oncol; 2010 Feb; 36(2):321-30. PubMed ID: 20043065
[TBL] [Abstract] [Full Text] [Related]
12. [Surgical treatment of esophageal carcinoma with cervical esophagogastrostomy by left thoracic esophagectomy].
Chen MY; Gao ZR; Xu JL; Wu S
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):301-3. PubMed ID: 19563704
[TBL] [Abstract] [Full Text] [Related]
13. foxa1 is a potential oncogene in anaplastic thyroid carcinoma.
Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
[TBL] [Abstract] [Full Text] [Related]
14. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
[TBL] [Abstract] [Full Text] [Related]
15. Myxoid liposarcoma. Experience with chemotherapy.
Patel SR; Burgess MA; Plager C; Papadopoulos NE; Linke KA; Benjamin RS
Cancer; 1994 Aug; 74(4):1265-9. PubMed ID: 8055448
[TBL] [Abstract] [Full Text] [Related]
